BNET Industries
Market Cap:$232.3M
Last Fiscal Year Sales:$130.2M
- Public
- US
Dow Jones Description
To become a leading specialty pharmaceutical company that acquires, develops and commercializes proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.
Number of Employees 345
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5
-
Santarus Inc executes licence agreement for ZEGERID products in Europe
-
Santarus Reports Second Quarter 2009 Financial Results
News & Analysis
Filter by
call transcript and santarus inc. - All News and Analysis
Santarus Inc. Q3 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Scott Henry - Roth Capital. Scott Henry - Roth Capital You certainly covered a lot in the prepared remarks, but just a couple of questions on the R&D side. First on Rifamycin, when do you expect to file the...
Santarus, Inc. Q2 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions Debra Crawford While we're waiting for questions, I'd like to mention we have some conference we'll be presenting at in the next several weeks, the BMO Capital Markets 9th Annual Focus on Health Care Conference this Wednesday, August 5th at the Millennium Broadway Hotel...
Santarus Inc. Q1 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Thank you. Operator Instructions Our first question comes from the line of Aaron Mishel with Thomas Weisel Partners. Aaron Mishel - Thomas Weisel Partners Hi. Congratulations on the quarter. Martha Hough Thank you. Aaron Mishel - Thomas Weisel Partners Few questions here. D you...
Santarus, Inc. Q4 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. Jerry Proehl While we are waiting for questions, I’d like to mention that we will be presenting at the 29th annual Cowan and Company healthcare conference on Tuesday, March 17th at the Boston Marriot Copley Place. We look forward to meeting you...
Santarus, Inc. (F3Q08) Earnings Call Transcript
Question-and-Answer SessionOperator Ladies and gentlemen Operator Instruction Gerald Proehl While we are waiting for questions, I would like to inform you that we will be presenting at the Rodman & Renshaw Tenth Annual Healthcare Conference, taking place at the New York Palace Hotel on November 12, at 9:55am eastern...
Santarus Inc. Q1 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions One moment, please, for the first question. Gerry Proehl While we are waiting for questions, we would like to inform you that we will be presenting at the Friedman, Billings, Ramsey Capital Markets Annual Spring Investor Conference on May 28th at 8:15 a.m., at the...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes


